Global Leading Market Research Publisher QYResearch announces the release of its latest report "Lung Monitoring Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Lung Monitoring Devices market, including market size, share, demand, industry development status, and forecasts for the next few years.

For pulmonologists, respiratory therapists, and home healthcare providers, measuring, monitoring, and evaluating lung function and respiratory health is essential for diagnosing and managing chronic respiratory diseases such as COPD, asthma, and pulmonary fibrosis. The global Lung Monitoring Devices market addresses this need through medical instruments including spirometers, peak flow meters, capnography devices, and advanced digital respiratory monitoring systems used in clinical, hospital, and homecare settings.

The global market for Lung Monitoring Devices was estimated to be worth US$ 11270 million in 2025 and is projected to reach US$ 20320 million, growing at a CAGR of 8.9% from 2026 to 2032. In 2024, global production reached approximately 12.5 million units, with an average global market price of around US$ 800 per unit. This growth reflects increasing respiratory disease prevalence and home monitoring adoption.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6097057/lung-monitoring-devices

Comprehensive Respiratory Assessment for Chronic Disease Management
Lung monitoring devices are medical instruments used to measure, monitor, and evaluate lung function and respiratory health. They include spirometers, peak flow meters, capnography devices, and advanced digital respiratory monitoring systems used in clinical, hospital, and homecare settings.

Spirometers measure forced expiratory volume (FEV1) and forced vital capacity (FVC) for COPD and asthma diagnosis. Peak flow meters provide daily variability monitoring for asthma action plans. Pulse oximeters track oxygen saturation (SpO2) in COPD and COVID-19 patients. Capnographs measure end-tidal CO2 (EtCO2) in ventilated and sedated patients.

Industry Segmentation: Device Types & Settings
The Lung Monitoring Devices market is segmented by product category and care environment:

Spirometers: Diagnostic devices for pulmonary function testing (PFT). A pulmonary clinic reported that digital spirometers reduced test time by 30%.

Pulse Oximeters: Finger-clip or handheld for oxygen saturation monitoring. A home care agency equips COPD patients with pulse oximeters for daily monitoring.

Peak Flow Meters: Handheld for asthma self-monitoring. An asthma educator recommends peak flow meters for all moderate-to-severe patients.

Sleep Test Devices: Home sleep apnea testing (HSAT) devices.

Gas Analyzers: Blood gas analyzers for critical care.

Capnographs: EtCO2 monitoring in anesthesia, ICU, and emergency settings.

Other Types of Devices: Incentive spirometers, respiratory muscle trainers.

Application Segments
Hospitals: ICU, emergency department, pulmonary function lab, and perioperative settings.

Clinics: Pulmonology and primary care offices.

Diagnostic Centers: Standalone PFT and sleep centers.

Homecare Settings: Home spirometry, pulse oximetry, and sleep testing. A COPD disease management program reported that home monitoring reduced hospital readmissions by 35%.

Technology Developments & Market Trends
Over the past six months, several advancements have shaped the market. Connected spirometers and pulse oximeters with Bluetooth for remote patient monitoring. AI-powered interpretation of pulmonary function tests. Wearable respiratory monitors for continuous tracking. Smartphone-integrated peak flow meters for asthma action plans.

The trend toward home-based pulmonary rehabilitation and remote monitoring post-COVID-19 drives adoption. Telehealth integration for virtual respiratory care visits. Pediatric-specific devices for asthma management in children.

Regional Market Dynamics
North America leads the lung monitoring devices market, driven by high COPD/asthma prevalence, remote monitoring adoption, and strong reimbursement. Europe follows, with robust respiratory care infrastructure. Asia-Pacific is the fastest-growing region, with increasing smoking-related respiratory disease and improving healthcare access in China, India, and Southeast Asia.

Competitive Landscape
Key players include Cosmed, DeVilbiss Healthcare, Drägerwerk, GE Healthcare, Haag-Streit Group, Hill-Rom Holdings (now Baxter), Masimo, Medline Industries, Medtronic, Nihon Kohden, nSpire Health, Omron Healthcare, Philips Healthcare, ResMed, Rossmax International, Smiths Medical, Teleflex, Trudell Medical International, Vitalograph, and Vyaire Medical.

Market Segmentation
The Lung Monitoring Devices market is segmented as below:

By Company

Cosmed

DeVilbiss Healthcare LLC

Drägerwerk AG & Co. KGaA

GE Healthcare

Haag-Streit Group

Hill-Rom Holdings (now Baxter)

Masimo Corporation

Medline Industries Inc.

Medtronic

Nihon Kohden Corporation

nSpire Health Inc.

Omron Healthcare Co. Ltd.

Philips Healthcare

ResMed Inc.

Rossmax International Ltd.

Smiths Medical

Teleflex Inc.

Trudell Medical International

Vitalograph Ltd

Vyaire Medical

Segment by Type

Spirometers

Pulse Oximeters

Peak Flow Meters

Sleep Test Devices

Gas Analyzers

Capnographs

Other Types of Devices

Segment by Application

Hospitals

Clinics

Diagnostic Centers

Homecare Settings

Exclusive Industry Outlook
Looking ahead, the convergence of lung monitoring devices with digital health, AI interpretation, and remote patient monitoring represents a significant growth opportunity. Development of continuous wearable respiratory monitors for COPD exacerbation prediction. Integration with electronic health records (EHR) for automated data capture. Additionally, the expansion of telehealth and home-based pulmonary rehabilitation will drive demand for connected, patient-friendly devices. The ability to offer lung monitoring devices that combine accuracy, connectivity, and ease of use—supported by clinical validation and reimbursement—will define competitive differentiation.

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp